{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:22:35Z","timestamp":1770524555644,"version":"3.49.0"},"reference-count":38,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T00:00:00Z","timestamp":1282608000000},"content-version":"vor","delay-in-days":7420,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Develop Med Child Neuro"],"published-print":{"date-parts":[[1990,5]]},"abstract":"<jats:sec><jats:title>SUMMARY<\/jats:title><jats:p>This study assessed potential teratogenic properties of benzodiazepine (BZD) intake during early pregnancy. Four neonatal diagnoses of congenital malformations (embryopathy and fetopathy, unspecified; unspecified congenital malformations of the nervous system; cleft palate and cleft lip; congenital malformations of the urinary tract) were selected. The authors' previous clinical experience had shown these diagnoses to be characteristic of infants born to mothers with excessive intake of BZD in early pregnancy. The selected diagnoses were present in 25 of 10,646 liveborn infants (2\u00b73 per 1000) delivered by mothers living in the city of Gothenburg in 1985 and 1986. In 18 of these cases, it was possible to analyse maternal plasma, and eight samples (44 per cent) were found to be BZD\u2010positive. Of 60 controls, two maternal blood samples (3 per cent) were positive for BZD. The difference is highly significant and suggests an association between these congenital malformations and BZD consumed during early gestation.<\/jats:p><\/jats:sec><jats:sec><jats:title>R\u00c9SUM\u00c9<\/jats:title><jats:p>Association entre malformations cong\u00e9nitales et consommation maternelle de benzodiaz\u00e9pines<\/jats:p><jats:p>Cette \u00e9tude appr\u00e9cie les propri\u00e9t\u00e9s t\u00e9ratog\u00e9niques potentielles des benzodiac\u00e9pines (BZD) prises en d\u00e9but de grossesse. Quatre diagnostics n\u00e9onataux de malformations cong\u00e9nitales (embryopathie ou foetopathie non sp\u00e9cifique; malformations cong\u00e9nitales non sp\u00e9cifiques du Syst\u00e8me Nerveux; fente palatine et bec de li\u00e8vre; malformations cong\u00e9nitales du tractus urinaire) ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es en fonction d'exp\u00e9riences cliniques ant\u00e9rieures qui les faisaient suppos\u00e9s caract\u00e9ristiques d'enfants n\u00e9s de m\u00e8res ayant consomm\u00e9 des BZD de fa\u00e7on excessive. Les diagnostics s\u00e9lectionn\u00e9es ont \u00e9t\u00e9 port\u00e9s chez 25 parmi 10\u00b7646 nourrissons n\u00e9s vivants (2,3 pour mille) de m\u00e8res vivant \u00e0 Goteborg (Su\u00e8de) en 1985 et 1986. Dans de ces cas, il a \u00e9t\u00e9 possible d'analyser le plasma maternel et huit \u00e9chantillons (44 pour cent) \u00e9taient positifs pour les BZD. La diff\u00e9rence est hautement significative et sugg\u00e8re une association entre ces malformations cong\u00e9nitales et les BZD consomm\u00e9es durant le d\u00e9but de grossesse.<\/jats:p><\/jats:sec><jats:sec><jats:title>ZUSAMMENFASSUNG<\/jats:title><jats:p>Beziehung zwischen kongenitalen Fehlbildungen und dem mutterlichen Konsum von Benzodiazepin<\/jats:p><jats:p>Diese Studie untersucht die m\u00f6glichen teratogenen Eigenschaften von Benzodiazepin (BZD) in der Fr\u00fahschwangerschaft. Es wurden vier neonatale Diagnosen kongenitaler Fehlbildungen (unspezifische Embryopathie und Fetopathie; unspezifische kongenitale Fehlbildungen des Nervensystems; Kieferspalte und Lippenspalte; kongenitale Fehlbildungen der Harnwege) ausgew\u00e4hlt, die aus klinischer Erfahrung charakteristisch f\u00f9r Kinder waren, deren M\u00fctter in der Fr\u00fchschwangerschaft hohe Dosen von BZD eingenommen hatten. Die ausgew\u00e4hlten Diagnosen fanden sich bei 25 von 10,646 lebend geborenen Kindern (2\u00b73 pro 1\u00b7000) von M\u00fcttern, die 1985 und 1986 in der Stradt G\u00f6teborg lebten. Bei 18 dieser F\u00e4lle gelang es, m\u00f9tterliches Plasma zu analysieren und acht der Proben (44 Prozent) waren BZD positiv. Von 60 Kontrolluntersuchungen waren zwei m\u00fctterliche Blutproben (3 Prozent) BZD positiv. Die Differenz ist hoch signifikant und deutet auf eine Beziehung zwischen diesen kongenitalen Fehlbildungen und BZD Einnahme in der Fr\u00fchschwagnerschaft hin.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESUMEN<\/jats:title><jats:p>Asociaci\u00f3n entre malformaciones cong\u00e9nitas y consumo materno de benzodiacepina<\/jats:p><jats:p>Este estudio evalu\u00f3 las propiedades potencialmente terat\u00f3genas de tomar Benzodiacepina (BZD) al inicio de la gestaci\u00f3n. Se seleccionaron cuatro diagn\u00f3sticos de malformaciones cong\u00e9nitas (embrio y fetopat\u00eda no especificada, malformaciones cong\u00e9nitas del sistema nervioso no especificadas, paladar hendido y malformaciones cong\u00e9nitas del sistema urinario) considerados por experiencia cl\u00ednica anterior como caracter\u00edsticos de ni\u00f1os nacidos de madres con excesivo consumo de BZD al inicio de la gestaci\u00f3n. Los diagn\u00f3sticos seleccionados estaban presentes en 25 de 10,646 lactantes vivos (2,3 por ciento), hijos de madres residentes en la ciudad de Ghotenburg en 1985 y 1986. En 18 de estos casos fue posible analizar el plasma materno y en ocho muestras (44 por ciento) se hall\u00f3 positividad para las BZD. En 60 controles, dos muestras de sangre materna (3 por ciento) eran positivas para las BZD. La diferencia es altamente significativa y sugiere una asociaci\u00f3n entre estas malformaciones cong\u00e9nitas y el consumo de BZD al inicio de la gestaci\u00f3n.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1469-8749.1990.tb16962.x","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T14:39:25Z","timestamp":1283956765000},"page":"432-441","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["CONGENITAL MALFORMATIONS AND MATERNAL CONSUMPTION OF BENZODIAZEPINES: A CASE\u2010CONTROL STUDY"],"prefix":"10.1111","volume":"32","author":[{"given":"Liv","family":"Laegreid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragnar","family":"Oleg\u00e2rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Conradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudrun","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Wahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,24]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92153-4"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.288.6424.1135"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197404042901404"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1980.tb04502.x"},{"key":"e_1_2_1_6_1","volume-title":"Drug Treatment of Neurotic Disorders.","author":"Clare A. W.","year":"1986"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5887.251"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)91654-8"},{"key":"e_1_2_1_9_1","first-page":"628","article-title":"In\u2010utero exposure to benzodiazepines.","volume":"1","author":"Czeizel A.","year":"1987","journal-title":"Lancet"},{"key":"e_1_2_1_10_1","first-page":"628","article-title":"In\u2010utero exposure to benzodiazepines.","volume":"1","author":"Gerhardsson M.","year":"1987","journal-title":"Lancet"},{"key":"e_1_2_1_11_1","volume-title":"Birth Defects and Drugs in Pregnancy.","author":"Heionen O. P.","year":"1977"},{"key":"e_1_2_1_12_1","first-page":"589","article-title":"Sales of psychotropic drugs in the Nordic countries.","volume":"15","author":"Hemminki E.","year":"1981","journal-title":"Social Science and Medicine"},{"key":"e_1_2_1_13_1","volume-title":"Perinatal Epidemiology.","author":"Holford T. R.","year":"1984"},{"key":"e_1_2_1_14_1","unstructured":"International Classification of Diseases Injuries and Causes of Death 1965\u20131968 revision in a Swedish rendition."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007998409109545"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700049126"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(87)80472-3"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91951-9"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80619-5"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197107000-00003"},{"key":"e_1_2_1_21_1","first-page":"37","article-title":"The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents.","volume":"2","author":"Majewski F.","year":"1981","journal-title":"International Journal of Biological Research in Pregnancy"},{"key":"e_1_2_1_22_1","volume-title":"Casarett and Doull's Toxicology: The Basic Science of Poisons","author":"Manson M. J.","year":"1986"},{"key":"e_1_2_1_23_1","volume-title":"The Benzodiazepines\u2014Use, Overuse, Misuse, Abuse?","author":"Marks J.","year":"1985"},{"key":"e_1_2_1_24_1","first-page":"175","article-title":"Occurrence of strabismus in infants born to drug\u2010dependent women.","volume":"141","author":"Nelson L. B.","year":"1987","journal-title":"American Journal of Diseases of Children"},{"key":"e_1_2_1_25_1","volume-title":"Current Topics in Pathology. Drug\u2010Induced Pathology.","author":"Neubert D.","year":"1980"},{"issue":"44","key":"e_1_2_1_26_1","first-page":"169","article-title":"Prenatal factors including fetal alcohol syndrome","author":"Oleg\u00e5rd R.","year":"1987","journal-title":"Uppsala Journal of Medical Sciences"},{"key":"e_1_2_1_27_1","volume-title":"Neurofibromatosis: Phenotype, Natural History and Pathogenesis.","author":"Riccardi V. M.","year":"1986"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198311243092103"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)90548-6"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/4.1.37"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00441734"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198410043111413"},{"key":"e_1_2_1_33_1","first-page":"823","article-title":"Pitfalls and prospects in clinical research on antianxiety drugs: benzodiazepines and placebo\u2014a research review.","volume":"39","author":"Solomon K.","year":"1978","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_2_1_34_1","unstructured":"Swedish Drug Statistics\u2014Annual Reports 1985; National Corporation of Swedish Pharmacies 1986."},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(74)80753-5"},{"key":"e_1_2_1_36_1","volume-title":"Neurology of the Newborn","author":"Volpe J. J.","year":"1987"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.59.11.1052"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90265-0"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)80749-5"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.1990.tb16962.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1469-8749.1990.tb16962.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T09:25:06Z","timestamp":1697966706000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1469-8749.1990.tb16962.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["10.1111\/j.1469-8749.1990.tb16962.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-8749.1990.tb16962.x","archive":["Portico"],"relation":{},"ISSN":["0012-1622","1469-8749"],"issn-type":[{"value":"0012-1622","type":"print"},{"value":"1469-8749","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]},"assertion":[{"value":"2010-08-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}